Linear ubiquitin chain-binding domains.
Autor: | Fennell LM; Institute of Molecular Biotechnology (IMBA), Vienna Biocenter (VBC), Austria., Rahighi S; Chapman University School of Pharmacy (CUSP), Harry and Diane Health Science Campus, Chapman University, Irvine, CA, USA., Ikeda F; Institute of Molecular Biotechnology (IMBA), Vienna Biocenter (VBC), Austria. |
---|---|
Jazyk: | angličtina |
Zdroj: | The FEBS journal [FEBS J] 2018 Aug; Vol. 285 (15), pp. 2746-2761. Date of Electronic Publication: 2018 Apr 30. |
DOI: | 10.1111/febs.14478 |
Abstrakt: | Ubiquitin modification (ubiquitination) of target proteins can vary with respect to chain lengths, linkage type, and chain forms, such as homologous, mixed, and branched ubiquitin chains. Thus, ubiquitination can generate multiple unique surfaces on a target protein substrate. Ubiquitin-binding domains (UBDs) recognize ubiquitinated substrates, by specifically binding to these unique surfaces, modulate the formation of cellular signaling complexes and regulate downstream signaling cascades. Among the eight different homotypic chain types, Met1-linked (also termed linear) chains are the only chains in which linkage occurs on a non-Lys residue of ubiquitin. Linear ubiquitin chains have been implicated in immune responses, cell death and autophagy, and several UBDs - specific for linear ubiquitin chains - have been identified. In this review, we describe the main principles of ubiquitin recognition by UBDs, focusing on linear ubiquitin chains and their roles in biology. (© 2018 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |